
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex Inc. demonstrates a favorable outlook due to anticipated stronger revenue growth, margin expansion, and the potential for accretive acquisitions. The company's focus on its Interventional business, particularly in cardiology, is expected to drive mid-single-digit organic growth, bolstered by recent market share gains following a competitor's exit. Additionally, planned cost reduction efforts are projected to enhance operating margins and support double-digit earnings growth, further solidifying Teleflex's financial position.
Bears say
Teleflex Inc. has faced downward revisions in its revenue forecasts, indicating an organic revenue growth rate of 2.1%, which is below the market expectations of approximately 2.7%, contributing to a negative outlook. The company is grappling with specific weaknesses in its Interventional and Interventional Urology segments, driven by lower order rates for intra-aortic balloon pumps (IABPs) and ongoing pressures in the UroLift system, posing significant growth challenges. Additionally, risks associated with larger acquisitions and the potential dilution of earnings per share (EPS) further underscore the concerns regarding future profitability and market position.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares